PTC Therapeutics Inc (STU:BH3)
€ 36.8 0 (0%) Market Cap: 2.89 Bil Enterprise Value: 2.25 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 66/100

PTC Therapeutics Inc at Barclays Global Healthcare Conference Transcript

Mar 14, 2023 / 12:00PM GMT
Release Date Price: €43 (+1.90%)
Huidong Wang
Barclays Bank PLC, Research Division - Research Analyst

Okay. Great. My name is Gena Wang. I'm SMID Cap biotech analyst at the Barclays. I'm so glad to see everyone here. This is the second, I think, a Global Healthcare Conference that in person, I remember last year. So this is the second year. I wanted to welcome to our Global Healthcare Conference. First, I wish everyone stay healthy and I would like to thank all the participants, investors, companies and especially our event team and corporate access team, who made this healthcare conference possible.

With that, I would like to introduce today's first presenting company, PTC Therapeutics. With us today, we have Matt Klein, Chief Operating Officer. We have Emily Hill, Chief Financial Officer. We also have Kylie O'Keefe, Senior VP of Commercial and Corporate Strategy. So maybe before I start with the questions, Emily, if you want to give a overview of the company.

Emily Luisa Hill
PTC Therapeutics, Inc. - CFO

Yes. Sure, Gena. Thank you for having us. Happy to be here. PTC is entering

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot